Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cerebral Hemorrhage | 11 | 2022 | 325 | 3.600 |
Why?
|
Hemangioma, Cavernous, Central Nervous System | 14 | 2020 | 223 | 3.260 |
Why?
|
Hemangioma, Cavernous | 4 | 2020 | 69 | 1.740 |
Why?
|
Thrombolytic Therapy | 4 | 2021 | 220 | 1.690 |
Why?
|
Tissue Plasminogen Activator | 3 | 2020 | 162 | 1.490 |
Why?
|
Craniotomy | 3 | 2021 | 88 | 1.450 |
Why?
|
Intracranial Hemorrhages | 5 | 2020 | 120 | 1.200 |
Why?
|
Minimally Invasive Surgical Procedures | 5 | 2022 | 237 | 1.090 |
Why?
|
Skull Base | 2 | 2023 | 47 | 1.040 |
Why?
|
Fibrinolytic Agents | 3 | 2020 | 202 | 0.970 |
Why?
|
Skull Base Neoplasms | 1 | 2023 | 11 | 0.910 |
Why?
|
Dura Mater | 2 | 2020 | 44 | 0.890 |
Why?
|
Headache | 1 | 2022 | 73 | 0.820 |
Why?
|
Central Nervous System Neoplasms | 2 | 2019 | 81 | 0.810 |
Why?
|
Decompression, Surgical | 2 | 2020 | 87 | 0.790 |
Why?
|
Disseminated Intravascular Coagulation | 1 | 2020 | 27 | 0.740 |
Why?
|
Spinal Cord Diseases | 1 | 2020 | 29 | 0.740 |
Why?
|
Cerebral Veins | 1 | 2020 | 30 | 0.740 |
Why?
|
Antiphospholipid Syndrome | 1 | 2020 | 20 | 0.740 |
Why?
|
Neurofibromatosis 1 | 1 | 2020 | 36 | 0.730 |
Why?
|
Decompressive Craniectomy | 1 | 2020 | 18 | 0.730 |
Why?
|
Intracranial Thrombosis | 1 | 2020 | 27 | 0.730 |
Why?
|
Puerperal Disorders | 1 | 2020 | 32 | 0.730 |
Why?
|
Time-to-Treatment | 1 | 2021 | 98 | 0.730 |
Why?
|
Proof of Concept Study | 1 | 2019 | 38 | 0.720 |
Why?
|
Anticoagulants | 2 | 2020 | 408 | 0.720 |
Why?
|
Transcriptome | 3 | 2020 | 580 | 0.700 |
Why?
|
Optic Chiasm | 1 | 2019 | 16 | 0.690 |
Why?
|
Paraganglioma | 1 | 2019 | 16 | 0.680 |
Why?
|
Sella Turcica | 1 | 2019 | 17 | 0.680 |
Why?
|
Cranial Fossa, Posterior | 1 | 2018 | 25 | 0.670 |
Why?
|
Cranial Fossa, Middle | 1 | 2018 | 11 | 0.670 |
Why?
|
Pituitary Neoplasms | 1 | 2019 | 62 | 0.660 |
Why?
|
Postoperative Hemorrhage | 1 | 2018 | 46 | 0.630 |
Why?
|
Thrombophilia | 1 | 2017 | 22 | 0.620 |
Why?
|
Arnold-Chiari Malformation | 1 | 2018 | 43 | 0.620 |
Why?
|
Central Nervous System Vascular Malformations | 1 | 2017 | 32 | 0.610 |
Why?
|
Medulla Oblongata | 1 | 2018 | 89 | 0.610 |
Why?
|
Thromboembolism | 1 | 2017 | 119 | 0.590 |
Why?
|
Adenoma | 1 | 2019 | 235 | 0.580 |
Why?
|
Apoptosis Regulatory Proteins | 5 | 2019 | 199 | 0.560 |
Why?
|
Protein Kinase Inhibitors | 1 | 2019 | 589 | 0.530 |
Why?
|
Biomarkers | 6 | 2020 | 1718 | 0.510 |
Why?
|
Gastrointestinal Microbiome | 2 | 2020 | 455 | 0.500 |
Why?
|
Humans | 37 | 2024 | 86643 | 0.500 |
Why?
|
Early Detection of Cancer | 1 | 2017 | 394 | 0.470 |
Why?
|
KRIT1 Protein | 5 | 2019 | 62 | 0.460 |
Why?
|
Adolescent | 8 | 2022 | 8981 | 0.430 |
Why?
|
Neurosurgical Procedures | 3 | 2023 | 213 | 0.400 |
Why?
|
Brain Neoplasms | 3 | 2020 | 763 | 0.370 |
Why?
|
Conservative Treatment | 2 | 2020 | 20 | 0.350 |
Why?
|
rho-Associated Kinases | 3 | 2019 | 159 | 0.340 |
Why?
|
Female | 20 | 2024 | 44532 | 0.340 |
Why?
|
Membrane Proteins | 4 | 2019 | 1196 | 0.330 |
Why?
|
Disease Progression | 4 | 2020 | 1531 | 0.320 |
Why?
|
Middle Aged | 12 | 2024 | 25028 | 0.320 |
Why?
|
Cohort Studies | 7 | 2020 | 2767 | 0.320 |
Why?
|
Young Adult | 7 | 2020 | 5976 | 0.300 |
Why?
|
Male | 18 | 2024 | 40965 | 0.300 |
Why?
|
Diagnosis, Differential | 2 | 2022 | 1565 | 0.280 |
Why?
|
Proto-Oncogene Proteins | 2 | 2019 | 645 | 0.270 |
Why?
|
Magnetic Resonance Imaging | 5 | 2020 | 3362 | 0.260 |
Why?
|
Aged | 9 | 2024 | 18415 | 0.250 |
Why?
|
Glioma | 2 | 2018 | 285 | 0.240 |
Why?
|
Adult | 12 | 2024 | 25648 | 0.240 |
Why?
|
Stroke | 2 | 2024 | 965 | 0.240 |
Why?
|
Treatment Outcome | 6 | 2024 | 7993 | 0.240 |
Why?
|
Child | 5 | 2022 | 6927 | 0.240 |
Why?
|
Cranial Fossa, Anterior | 1 | 2023 | 4 | 0.230 |
Why?
|
Vascular Endothelial Growth Factor A | 3 | 2020 | 407 | 0.230 |
Why?
|
rhoA GTP-Binding Protein | 2 | 2020 | 83 | 0.220 |
Why?
|
Brain | 4 | 2020 | 2216 | 0.220 |
Why?
|
Neoplasms | 1 | 2017 | 2898 | 0.220 |
Why?
|
Myocardium | 3 | 2010 | 529 | 0.210 |
Why?
|
Frontal Lobe | 1 | 2023 | 130 | 0.210 |
Why?
|
Recovery of Function | 3 | 2019 | 272 | 0.200 |
Why?
|
Embolization, Therapeutic | 1 | 2024 | 238 | 0.200 |
Why?
|
ADAMTS5 Protein | 1 | 2020 | 4 | 0.190 |
Why?
|
Versicans | 1 | 2020 | 6 | 0.190 |
Why?
|
Child, Preschool | 4 | 2020 | 3612 | 0.190 |
Why?
|
Plasma | 1 | 2020 | 50 | 0.190 |
Why?
|
Pilot Projects | 2 | 2020 | 839 | 0.190 |
Why?
|
Dilatation, Pathologic | 1 | 2020 | 54 | 0.190 |
Why?
|
Hemorrhage | 2 | 2019 | 268 | 0.190 |
Why?
|
Ventriculostomy | 1 | 2020 | 26 | 0.180 |
Why?
|
Intestines | 2 | 2020 | 411 | 0.180 |
Why?
|
Endothelium, Vascular | 2 | 2020 | 435 | 0.180 |
Why?
|
Neurotoxins | 1 | 2020 | 49 | 0.180 |
Why?
|
Intracellular Signaling Peptides and Proteins | 2 | 2019 | 379 | 0.180 |
Why?
|
Head Injuries, Penetrating | 1 | 2020 | 54 | 0.180 |
Why?
|
Metagenomics | 1 | 2020 | 83 | 0.180 |
Why?
|
Wounds, Gunshot | 1 | 2020 | 71 | 0.170 |
Why?
|
Botulinum Toxins, Type A | 1 | 2020 | 49 | 0.170 |
Why?
|
DNA, Bacterial | 1 | 2020 | 236 | 0.170 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2020 | 241 | 0.170 |
Why?
|
Protein C | 1 | 2018 | 5 | 0.170 |
Why?
|
Thrombomodulin | 1 | 2018 | 7 | 0.170 |
Why?
|
Signal Transduction | 6 | 2020 | 3241 | 0.170 |
Why?
|
Computed Tomography Angiography | 1 | 2020 | 131 | 0.170 |
Why?
|
Phosphoproteins | 2 | 2010 | 254 | 0.170 |
Why?
|
Supratentorial Neoplasms | 1 | 2018 | 10 | 0.170 |
Why?
|
Encephalomalacia | 1 | 2018 | 3 | 0.160 |
Why?
|
Magnetite Nanoparticles | 1 | 2018 | 27 | 0.160 |
Why?
|
Feces | 1 | 2020 | 319 | 0.160 |
Why?
|
Paresthesia | 1 | 2018 | 16 | 0.160 |
Why?
|
Dog Diseases | 1 | 2018 | 35 | 0.160 |
Why?
|
Myosin Type II | 1 | 2018 | 50 | 0.160 |
Why?
|
Laminectomy | 1 | 2018 | 27 | 0.160 |
Why?
|
Cell Membrane Permeability | 1 | 2018 | 119 | 0.160 |
Why?
|
Follow-Up Studies | 3 | 2020 | 3640 | 0.160 |
Why?
|
Movement Disorders | 1 | 2018 | 44 | 0.160 |
Why?
|
Endothelial Cells | 4 | 2019 | 428 | 0.160 |
Why?
|
Adrenergic beta-Agonists | 2 | 2009 | 72 | 0.160 |
Why?
|
Dacarbazine | 1 | 2018 | 102 | 0.160 |
Why?
|
Gastrointestinal Tract | 1 | 2019 | 191 | 0.150 |
Why?
|
Neuroimaging | 1 | 2018 | 113 | 0.150 |
Why?
|
Feasibility Studies | 1 | 2019 | 751 | 0.150 |
Why?
|
Intestinal Mucosa | 2 | 2019 | 797 | 0.150 |
Why?
|
Combined Modality Therapy | 3 | 2019 | 1686 | 0.140 |
Why?
|
Tomography, X-Ray Computed | 3 | 2021 | 2601 | 0.140 |
Why?
|
Enzyme Inhibitors | 1 | 2019 | 639 | 0.140 |
Why?
|
Aging | 1 | 2020 | 691 | 0.130 |
Why?
|
Double-Blind Method | 1 | 2019 | 1823 | 0.130 |
Why?
|
Antineoplastic Agents | 2 | 2018 | 2360 | 0.130 |
Why?
|
Seizures | 1 | 2017 | 297 | 0.130 |
Why?
|
Oncolytic Virotherapy | 1 | 2015 | 41 | 0.130 |
Why?
|
Heart Failure | 3 | 2010 | 1204 | 0.130 |
Why?
|
Retrospective Studies | 4 | 2024 | 8489 | 0.120 |
Why?
|
Mice, Knockout | 5 | 2019 | 1924 | 0.120 |
Why?
|
Microfilament Proteins | 2 | 2018 | 208 | 0.120 |
Why?
|
Apoptosis | 2 | 2018 | 1683 | 0.120 |
Why?
|
Infant | 1 | 2020 | 3046 | 0.120 |
Why?
|
Mice | 8 | 2020 | 11352 | 0.120 |
Why?
|
Cytokines | 1 | 2017 | 776 | 0.120 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2019 | 1204 | 0.110 |
Why?
|
Hypertension | 1 | 2022 | 1141 | 0.110 |
Why?
|
Chicago | 1 | 2017 | 1379 | 0.110 |
Why?
|
Practice Guidelines as Topic | 1 | 2020 | 1036 | 0.110 |
Why?
|
Prospective Studies | 2 | 2019 | 4213 | 0.110 |
Why?
|
Cross-Sectional Studies | 1 | 2017 | 1621 | 0.110 |
Why?
|
Gene Expression Profiling | 2 | 2008 | 1384 | 0.100 |
Why?
|
Risk Factors | 2 | 2022 | 5417 | 0.100 |
Why?
|
MAP Kinase Kinase Kinase 3 | 2 | 2020 | 12 | 0.090 |
Why?
|
Sarcomeres | 1 | 2010 | 23 | 0.090 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2010 | 36 | 0.090 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2010 | 74 | 0.090 |
Why?
|
Animals | 9 | 2020 | 26582 | 0.090 |
Why?
|
Ventricular Remodeling | 1 | 2010 | 96 | 0.090 |
Why?
|
Clenbuterol | 1 | 2009 | 2 | 0.090 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2010 | 222 | 0.090 |
Why?
|
Neovascularization, Physiologic | 1 | 2010 | 133 | 0.090 |
Why?
|
Adrenergic beta-2 Receptor Agonists | 1 | 2009 | 23 | 0.090 |
Why?
|
Mice, Inbred C57BL | 4 | 2020 | 3092 | 0.080 |
Why?
|
RNA Splicing | 1 | 2010 | 142 | 0.080 |
Why?
|
Mice, Transgenic | 3 | 2019 | 1540 | 0.080 |
Why?
|
Postoperative Complications | 1 | 2018 | 2207 | 0.080 |
Why?
|
Myocytes, Cardiac | 1 | 2010 | 275 | 0.080 |
Why?
|
Stem Cells | 1 | 2009 | 351 | 0.070 |
Why?
|
Cardiomyopathies | 1 | 2009 | 240 | 0.070 |
Why?
|
Cell Proliferation | 2 | 2010 | 1578 | 0.070 |
Why?
|
Longitudinal Studies | 2 | 2020 | 1019 | 0.070 |
Why?
|
Disease Models, Animal | 3 | 2020 | 2232 | 0.070 |
Why?
|
Radial Artery | 1 | 2024 | 33 | 0.060 |
Why?
|
Time Factors | 3 | 2021 | 5210 | 0.060 |
Why?
|
Catheters | 1 | 2024 | 74 | 0.060 |
Why?
|
Thrombectomy | 1 | 2024 | 158 | 0.050 |
Why?
|
ADAMTS4 Protein | 1 | 2020 | 4 | 0.050 |
Why?
|
ADAMTS1 Protein | 1 | 2020 | 6 | 0.050 |
Why?
|
Clinical Trials, Phase III as Topic | 1 | 2021 | 172 | 0.050 |
Why?
|
Mice, Inbred DBA | 1 | 2020 | 148 | 0.050 |
Why?
|
Proteolysis | 1 | 2020 | 100 | 0.050 |
Why?
|
Aged, 80 and over | 2 | 2021 | 6509 | 0.050 |
Why?
|
Endothelium | 1 | 2020 | 59 | 0.050 |
Why?
|
Myosin Heavy Chains | 2 | 2010 | 88 | 0.050 |
Why?
|
Dextran Sulfate | 1 | 2019 | 68 | 0.040 |
Why?
|
White Matter | 1 | 2020 | 80 | 0.040 |
Why?
|
RNA, Messenger | 3 | 2010 | 1981 | 0.040 |
Why?
|
Migraine Disorders | 1 | 2020 | 40 | 0.040 |
Why?
|
Permeability | 1 | 2019 | 137 | 0.040 |
Why?
|
Toll-Like Receptor 4 | 1 | 2019 | 88 | 0.040 |
Why?
|
Toll-Like Receptors | 1 | 2020 | 92 | 0.040 |
Why?
|
Endothelial Protein C Receptor | 1 | 2018 | 4 | 0.040 |
Why?
|
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine | 1 | 2019 | 36 | 0.040 |
Why?
|
Heart-Assist Devices | 1 | 2006 | 731 | 0.040 |
Why?
|
Cardiomyopathy, Dilated | 2 | 2010 | 97 | 0.040 |
Why?
|
Epithelium | 1 | 2020 | 319 | 0.040 |
Why?
|
Survivors | 1 | 2020 | 226 | 0.040 |
Why?
|
Genetic Association Studies | 1 | 2020 | 294 | 0.040 |
Why?
|
Tight Junctions | 1 | 2020 | 149 | 0.040 |
Why?
|
X-Ray Microtomography | 1 | 2019 | 80 | 0.040 |
Why?
|
Convection | 1 | 2018 | 12 | 0.040 |
Why?
|
Caco-2 Cells | 1 | 2018 | 123 | 0.040 |
Why?
|
Inflammation Mediators | 1 | 2019 | 154 | 0.040 |
Why?
|
Simvastatin | 1 | 2019 | 106 | 0.040 |
Why?
|
Hematoma | 1 | 2019 | 104 | 0.040 |
Why?
|
Lipopolysaccharide Receptors | 1 | 2018 | 23 | 0.040 |
Why?
|
Artificial Intelligence | 1 | 2021 | 298 | 0.040 |
Why?
|
Ligands | 1 | 2019 | 433 | 0.040 |
Why?
|
Occludin | 1 | 2018 | 66 | 0.040 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2019 | 318 | 0.040 |
Why?
|
Blood Coagulation | 1 | 2018 | 91 | 0.040 |
Why?
|
Interleukin-1beta | 1 | 2018 | 78 | 0.040 |
Why?
|
Dexamethasone | 1 | 2019 | 326 | 0.040 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2021 | 466 | 0.040 |
Why?
|
Databases, Factual | 1 | 2021 | 814 | 0.040 |
Why?
|
Disease Management | 1 | 2020 | 327 | 0.040 |
Why?
|
Homeostasis | 1 | 2020 | 409 | 0.040 |
Why?
|
Iron | 1 | 2018 | 164 | 0.040 |
Why?
|
Matrix Metalloproteinase 2 | 1 | 2017 | 44 | 0.040 |
Why?
|
Area Under Curve | 1 | 2018 | 334 | 0.040 |
Why?
|
Chronic Pain | 1 | 2020 | 145 | 0.040 |
Why?
|
Dogs | 1 | 2018 | 685 | 0.040 |
Why?
|
Magnetic Resonance Angiography | 1 | 2020 | 262 | 0.040 |
Why?
|
Up-Regulation | 2 | 2010 | 712 | 0.040 |
Why?
|
Phantoms, Imaging | 1 | 2019 | 429 | 0.040 |
Why?
|
Tumor Burden | 1 | 2018 | 289 | 0.040 |
Why?
|
Machine Learning | 1 | 2019 | 232 | 0.040 |
Why?
|
Polymers | 1 | 2018 | 202 | 0.040 |
Why?
|
Interleukin-6 | 1 | 2018 | 256 | 0.040 |
Why?
|
Gene Regulatory Networks | 1 | 2019 | 296 | 0.040 |
Why?
|
Drug Delivery Systems | 1 | 2018 | 178 | 0.040 |
Why?
|
Nanoparticles | 1 | 2018 | 157 | 0.040 |
Why?
|
Colitis | 1 | 2019 | 239 | 0.040 |
Why?
|
Receptors, Cell Surface | 1 | 2018 | 286 | 0.040 |
Why?
|
Actin Cytoskeleton | 1 | 2018 | 192 | 0.040 |
Why?
|
Predictive Value of Tests | 1 | 2021 | 1673 | 0.040 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2010 | 879 | 0.040 |
Why?
|
Cerebellum | 1 | 2018 | 247 | 0.040 |
Why?
|
Cluster Analysis | 1 | 2017 | 369 | 0.040 |
Why?
|
Acute Disease | 1 | 2018 | 826 | 0.040 |
Why?
|
Carrier Proteins | 1 | 2019 | 673 | 0.030 |
Why?
|
Phosphorylation | 1 | 2018 | 1106 | 0.030 |
Why?
|
ROC Curve | 1 | 2018 | 752 | 0.030 |
Why?
|
Epithelial Cells | 1 | 2019 | 669 | 0.030 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2019 | 378 | 0.030 |
Why?
|
Chronic Disease | 1 | 2018 | 971 | 0.030 |
Why?
|
Case-Control Studies | 1 | 2018 | 1805 | 0.030 |
Why?
|
B-Lymphocytes | 1 | 2018 | 724 | 0.030 |
Why?
|
Sensitivity and Specificity | 1 | 2018 | 1991 | 0.030 |
Why?
|
Reproducibility of Results | 1 | 2019 | 2705 | 0.030 |
Why?
|
Biomarkers, Tumor | 1 | 2020 | 1464 | 0.030 |
Why?
|
T-Lymphocytes | 1 | 2018 | 1195 | 0.030 |
Why?
|
Phenotype | 1 | 2018 | 2378 | 0.030 |
Why?
|
Filamins | 1 | 2010 | 19 | 0.020 |
Why?
|
Troponin I | 1 | 2010 | 27 | 0.020 |
Why?
|
Contractile Proteins | 1 | 2010 | 54 | 0.020 |
Why?
|
Troponin T | 1 | 2010 | 37 | 0.020 |
Why?
|
Leukemia Inhibitory Factor | 1 | 2009 | 4 | 0.020 |
Why?
|
Carboxypeptidases A | 1 | 2009 | 11 | 0.020 |
Why?
|
Chemokine CCL22 | 1 | 2009 | 5 | 0.020 |
Why?
|
Tissue Inhibitor of Metalloproteinase-1 | 1 | 2009 | 17 | 0.020 |
Why?
|
Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2009 | 44 | 0.020 |
Why?
|
LIM Domain Proteins | 1 | 2009 | 25 | 0.020 |
Why?
|
Aspartate Aminotransferases | 1 | 2009 | 73 | 0.020 |
Why?
|
Receptors, Adrenergic, beta-2 | 1 | 2009 | 36 | 0.020 |
Why?
|
Fibroblast Growth Factor 2 | 1 | 2009 | 57 | 0.020 |
Why?
|
Injections, Subcutaneous | 1 | 2009 | 117 | 0.020 |
Why?
|
Ion Transport | 1 | 2008 | 81 | 0.020 |
Why?
|
Apolipoprotein A-I | 1 | 2009 | 71 | 0.020 |
Why?
|
Myocardial Ischemia | 1 | 2010 | 162 | 0.020 |
Why?
|
Blotting, Western | 1 | 2010 | 782 | 0.020 |
Why?
|
Aortic Valve Stenosis | 1 | 2010 | 131 | 0.020 |
Why?
|
Muscle Proteins | 1 | 2009 | 132 | 0.020 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2010 | 302 | 0.020 |
Why?
|
C-Reactive Protein | 1 | 2009 | 190 | 0.020 |
Why?
|
Exons | 1 | 2010 | 450 | 0.020 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2008 | 115 | 0.020 |
Why?
|
Heart | 1 | 2010 | 539 | 0.020 |
Why?
|
Mutation | 1 | 2018 | 3968 | 0.020 |
Why?
|
DNA Damage | 1 | 2008 | 366 | 0.020 |
Why?
|
Computational Biology | 1 | 2010 | 528 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 2010 | 937 | 0.020 |
Why?
|
Stroke Volume | 1 | 2009 | 456 | 0.020 |
Why?
|
Gene Expression | 1 | 2010 | 1284 | 0.020 |
Why?
|
Sex Factors | 1 | 2008 | 1054 | 0.020 |
Why?
|
Ventricular Function, Left | 1 | 2009 | 592 | 0.020 |
Why?
|
Heart Ventricles | 1 | 2010 | 760 | 0.020 |
Why?
|
Hypoxia | 1 | 2010 | 641 | 0.020 |
Why?
|
Cells, Cultured | 1 | 2010 | 2818 | 0.020 |
Why?
|
Age Factors | 1 | 2008 | 1851 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2009 | 1920 | 0.010 |
Why?
|